134 related articles for article (PubMed ID: 34427100)
21. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
Lee Y; Itahana Y; Ong CC; Itahana K
J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
[TBL] [Abstract][Full Text] [Related]
23. Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.
Liu R; Blower PE; Pham AN; Fang J; Dai Z; Wise C; Green B; Teitel CH; Ning B; Ling W; Lyn-Cook BD; Kadlubar FF; Sadée W; Huang Y
Mol Pharmacol; 2007 Dec; 72(6):1637-46. PubMed ID: 17875604
[TBL] [Abstract][Full Text] [Related]
24. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.
Drayton RM; Dudziec E; Peter S; Bertz S; Hartmann A; Bryant HE; Catto JW
Clin Cancer Res; 2014 Apr; 20(7):1990-2000. PubMed ID: 24516043
[TBL] [Abstract][Full Text] [Related]
26. RNAi-mediated
Yang N; Mu L; Zhao B; Wang M; Hu S; Zhao B; Chen Y; Wu X
J Genet; 2018 Jun; 97(2):463-468. PubMed ID: 29932066
[TBL] [Abstract][Full Text] [Related]
27. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
Zhang Y; Koppula P; Gan B
Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
[TBL] [Abstract][Full Text] [Related]
28. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
He J; Wang X; Chen K; Zhang M; Wang J
Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
[TBL] [Abstract][Full Text] [Related]
29. Redox States of Protein Cysteines in Pathways of Protein Turnover and Cytoskeleton Dynamics Are Changed with Aging and Reversed by Slc7a11 Restoration in Mouse Lung Fibroblasts.
Zheng Y; Merchant ML; Burke TJ; Ritzenthaler JD; Li M; Gaweda AE; Benz FW; Roman J; Watson WH
Oxid Med Cell Longev; 2020; 2020():2468986. PubMed ID: 32587657
[TBL] [Abstract][Full Text] [Related]
30. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
[TBL] [Abstract][Full Text] [Related]
31. Age-dependent oxidation of extracellular cysteine/cystine redox state (E
Zheng Y; Ritzenthaler JD; Burke TJ; Otero J; Roman J; Watson WH
Free Radic Biol Med; 2018 Apr; 118():13-22. PubMed ID: 29458149
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
Future Oncol; 2018 Apr; 14(10):927-936. PubMed ID: 29528250
[TBL] [Abstract][Full Text] [Related]
33. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
Teramoto K; Katoh H
Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
Hu K; Li K; Lv J; Feng J; Chen J; Wu H; Cheng F; Jiang W; Wang J; Pei H; Chiao PJ; Cai Z; Chen Y; Liu M; Pang X
J Clin Invest; 2020 Apr; 130(4):1752-1766. PubMed ID: 31874110
[TBL] [Abstract][Full Text] [Related]
35. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
36. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
Jyotsana N; Ta KT; DelGiorno KE
Front Oncol; 2022; 12():858462. PubMed ID: 35280777
[TBL] [Abstract][Full Text] [Related]
37. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional Regulation of Amino Acid Transport in Glioblastoma Multiforme.
Umans RA; Martin J; Harrigan ME; Patel DC; Chaunsali L; Roshandel A; Iyer K; Powell MD; Oestreich K; Sontheimer H
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944790
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning, mRNA expression and tissue distribution analysis of Slc7a11 gene in alpaca (Lama paco) skins associated with different coat colors.
Tian X; Meng X; Wang L; Song Y; Zhang D; Ji Y; Li X; Dong C
Gene; 2015 Jan; 555(2):88-94. PubMed ID: 25455099
[TBL] [Abstract][Full Text] [Related]
40. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
